Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
White soft paraffin 50% / Liquid paraffin 50% ointment
130201000AAA6A6
|
Generic compound emollients | Other emollient preparations | Skin | 40,194 |
|
Isopropyl myristate 15% / Liquid paraffin 15% gel
130201000AACACA
|
Generic compound emollients | Other emollient preparations | Skin | 15,196 |
|
White soft paraffin 15% / Liquid paraffin light 6% cream
130201000AACDCD
|
Generic compound emollients | Other emollient preparations | Skin | 2,110 |
|
White soft paraffin 95% / Liquid paraffin 5% ointment
130201000AAA3A3
|
Generic compound emollients | Other emollient preparations | Skin | 938 |
|
Emulsifying ointment 50% / Liquid paraffin 50% ointment
130201000AADMDM
|
Generic compound emollients | Other emollient preparations | Skin | 109 |
|
White soft paraffin 15% / Liquid paraffin 6% cream
130201000AADLDL
|
Generic compound emollients | Other emollient preparations | Skin | 103 |
|
Generic Eucerin UreaRepair Plus 10% urea lotion
130201000AADRDR
|
Generic compound emollients | Other emollient preparations | Skin | 91 |
|
Propylene glycol 40% in Aqueous cream
130201000AACNCN
|
Generic compound emollients | Other emollient preparations | Skin | 5 |
|
Evening primrose oil 20% cream
130201000AACGCG
|
Generic compound emollients | Other emollient preparations | Skin | 3 |
|
Coconut oil 50% in White soft paraffin
130201000AADHDH
|
Generic compound emollients | Other emollient preparations | Skin | 2 |
|
Generic E45 cream
130201000AAALAL
|
Generic compound emollients | Other emollient preparations | Skin | 2 |
|
Glycerol 40% cream
130201000AABXBX
|
Generic compound emollients | Other emollient preparations | Skin | 2 |
|
Propylene glycol 40% in Clobetasone 0.05% cream
130201000AADJDJ
|
Generic compound emollients | Other emollient preparations | Skin | 2 |
|
Generic Aveeno cream
130201000AAA8A8
|
Generic compound emollients | Other emollient preparations | Skin | 1 |
|
Generic Dermol 500 lotion
130201000AABWBW
|
Generic compound emollients | Other emollient preparations | Skin | 1 |
|
White soft paraffin 75% / Liquid paraffin 25% ointment
130201000AACWCW
|
Generic compound emollients | Other emollient preparations | Skin | 1 |
|
Cetrimide 0.2% / Benzalkonium chloride 0.1% cream
130201000AACXCX
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Chamomile extract 10.5% ointment
130201000AAAQAQ
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Evening primrose oil 0.87% cream
130201000AACYCY
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Generic Alcoderm cream
130201000AAARAR
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Generic AquaBar
130201000AACHCH
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Generic Aveeno Daily moisturising hand cream
130201000AADQDQ
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Generic Aveeno lotion
130201000AACBCB
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Generic Diprobase cream
130201000AAA4A4
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Generic Unguentum M cream
130201000AAA5A5
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.